{"id":52419,"date":"2022-12-29T16:02:10","date_gmt":"2022-12-29T15:02:10","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/rockley-photonics-receives-2020-uk-rd-tax-credit-and-files-2021-rd-tax-credit-application\/"},"modified":"2022-12-29T16:02:10","modified_gmt":"2022-12-29T15:02:10","slug":"rockley-photonics-receives-2020-uk-rd-tax-credit-and-files-2021-rd-tax-credit-application","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/rockley-photonics-receives-2020-uk-rd-tax-credit-and-files-2021-rd-tax-credit-application\/","title":{"rendered":"Rockley Photonics Receives 2020 UK R&D Tax Credit and Files 2021 R&D Tax Credit Application"},"content":{"rendered":"
\n

OXFORD, England & PASADENA, Calif.–(BUSINESS WIRE)–$RKLY<\/a> #HMRC<\/a>–Rockley Photonics Holdings Limited (NYSE: RKLY) (\u201cRockley\u201d), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced that it received 12.9 million pounds sterling ($15.5 million) for its fiscal 2020 R&D tax credit from HMRC, the tax agency of the UK government. The Company filed its fiscal 2021 R&D tax credit application and expects to file its fiscal 2022 R&D tax credit application in 2023.\n<\/p>\n

<\/a><\/p>\n

\nAbout Rockley Photonics<\/strong>\n<\/p>\n

\nFormed in 2013, Rockley is a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions that target a portfolio of biomarkers. Rockley’s ground-breaking end-to-end biosensing platform unlocks unique spectra-based biomarkers enabling insights into personal health and well-being. With next-generation biosensing platforms specifically designed for mobile health monitoring, Rockley is laying the foundation for a new generation of biomedical applications across multiple industries.\n<\/p>\n

\nTo learn more about Rockley, visit rockleyphotonics.com<\/a>.\n<\/p>\n

\nCautionary Note Regarding Forward-Looking Statements<\/strong>\n<\/p>\n

\nStatements in this press release that are not historical facts constitute \u201cforward-looking statements\u201d for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include statements regarding Rockley\u2019s future expectations, beliefs, plans, objectives, and assumptions regarding future events or performance. The words \u201caccelerate,\u201d \u201cadvance,\u201d \u201canticipate,\u201d \u201cbelieve,\u201d \u201ccan,\u201d \u201ccapability,\u201d \u201ccontinue,\u201d \u201ccould,\u201d \u201cdevelop,\u201d \u201cenable,\u201d \u201cenhance\u201d, \u201cestimate,\u201d \u201ceventual,\u201d \u201cexpand, \u201cexpect,\u201d \u201cfocus,\u201d \u201cforward,\u201d \u201cfuture,\u201d \u201cgoal,\u201d \u201cground-breaking\u201d \u201cintend,\u201d \u201cmay,\u201d \u201cmight,\u201d \u201copportunity,\u201d \u201coutlook,\u201d \u201cplan,\u201d \u201cpossible,\u201d \u201cposition,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201crevolutionize,\u201d \u201cseem,\u201d \u201cshould,\u201d \u201ctrend,\u201d \u201cvision,\u201d \u201cwill,\u201d \u201cwould\u201d or other terms that predict or indicate future events, trends, or expectations, and similar expressions or the negative of such expressions may identify forward-looking statements, but the absence of these words or terms does not mean that a statement is not forward-looking. Forward-looking statements in this press release include, but are not limited to, statements regarding the following: (a) the timing of tax grant applications and expected receipt of future tax grants; and (b) our belief that we are laying the foundation for a new generation of applications across multiple industries, and the extent to which we may expand our focus beyond biosensing solutions.\n<\/p>\n

\nForward-looking statements are subject to several risks, assumptions, and uncertainties (many of which are beyond Rockley\u2019s control) that may cause actual results or performance to differ materially from those expressed or implied by these forward-looking statements. These risks, assumptions, and uncertainties include, but are not limited to, the factors described under the heading \u201cRisk Factors\u201d in our Annual Report on Form 10-K for the year ended December 31, 2021, and in other documents we file with the Securities and Exchange Commission. If any of these risks or uncertainties materialize, or should any of these assumptions prove incorrect, actual results may differ materially from those discussed in or implied by these forward-looking statements. There can be no assurance that future developments affecting Rockley will be those that have been anticipated. Given these risks and uncertainties, you should not place undue reliance on these forward-looking statements. These forward-looking statements speak only as of the date hereof and Rockley does not intend to update or revise any forward-looking statements, whether because of new information, future events, or otherwise, except as required by law.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nContact Information<\/strong>
Gwyn Lauber
\n
Rockley Photonics
\n
Telephone: +1 626-995-0001
\n
Email: investors@rockleyphotonics.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

OXFORD, England & PASADENA, Calif.–(BUSINESS WIRE)–$RKLY #HMRC–Rockley Photonics Holdings Limited (NYSE: RKLY) (\u201cRockley\u201d), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced that it received 12.9 million pounds sterling ($15.5 million) for its fiscal 2020 R&D tax credit from HMRC, the tax … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52419","6":"format-standard","7":"category-industry"},"yoast_head":"\nRockley Photonics Receives 2020 UK R&D Tax Credit and Files 2021 R&D Tax Credit Application - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/rockley-photonics-receives-2020-uk-rd-tax-credit-and-files-2021-rd-tax-credit-application\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rockley Photonics Receives 2020 UK R&D Tax Credit and Files 2021 R&D Tax Credit Application - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"OXFORD, England & PASADENA, Calif.–(BUSINESS WIRE)–$RKLY #HMRC–Rockley Photonics Holdings Limited (NYSE: RKLY) (\u201cRockley\u201d), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced that it received 12.9 million pounds sterling ($15.5 million) for its fiscal 2020 R&D tax credit from HMRC, the tax ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/rockley-photonics-receives-2020-uk-rd-tax-credit-and-files-2021-rd-tax-credit-application\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-29T15:02:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221229005044\/en\/1333692\/21\/Rockley-logo-500-x-500.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rockley-photonics-receives-2020-uk-rd-tax-credit-and-files-2021-rd-tax-credit-application\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rockley-photonics-receives-2020-uk-rd-tax-credit-and-files-2021-rd-tax-credit-application\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Rockley Photonics Receives 2020 UK R&D Tax Credit and Files 2021 R&D Tax Credit Application\",\"datePublished\":\"2022-12-29T15:02:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rockley-photonics-receives-2020-uk-rd-tax-credit-and-files-2021-rd-tax-credit-application\\\/\"},\"wordCount\":571,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rockley-photonics-receives-2020-uk-rd-tax-credit-and-files-2021-rd-tax-credit-application\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221229005044\\\/en\\\/1333692\\\/21\\\/Rockley-logo-500-x-500.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rockley-photonics-receives-2020-uk-rd-tax-credit-and-files-2021-rd-tax-credit-application\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rockley-photonics-receives-2020-uk-rd-tax-credit-and-files-2021-rd-tax-credit-application\\\/\",\"name\":\"Rockley Photonics Receives 2020 UK R&D Tax Credit and Files 2021 R&D Tax Credit Application - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rockley-photonics-receives-2020-uk-rd-tax-credit-and-files-2021-rd-tax-credit-application\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rockley-photonics-receives-2020-uk-rd-tax-credit-and-files-2021-rd-tax-credit-application\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221229005044\\\/en\\\/1333692\\\/21\\\/Rockley-logo-500-x-500.jpg\",\"datePublished\":\"2022-12-29T15:02:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rockley-photonics-receives-2020-uk-rd-tax-credit-and-files-2021-rd-tax-credit-application\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rockley-photonics-receives-2020-uk-rd-tax-credit-and-files-2021-rd-tax-credit-application\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rockley-photonics-receives-2020-uk-rd-tax-credit-and-files-2021-rd-tax-credit-application\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221229005044\\\/en\\\/1333692\\\/21\\\/Rockley-logo-500-x-500.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221229005044\\\/en\\\/1333692\\\/21\\\/Rockley-logo-500-x-500.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rockley-photonics-receives-2020-uk-rd-tax-credit-and-files-2021-rd-tax-credit-application\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rockley Photonics Receives 2020 UK R&D Tax Credit and Files 2021 R&D Tax Credit Application\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rockley Photonics Receives 2020 UK R&D Tax Credit and Files 2021 R&D Tax Credit Application - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/rockley-photonics-receives-2020-uk-rd-tax-credit-and-files-2021-rd-tax-credit-application\/","og_locale":"en_US","og_type":"article","og_title":"Rockley Photonics Receives 2020 UK R&D Tax Credit and Files 2021 R&D Tax Credit Application - Pharma Trend","og_description":"OXFORD, England & PASADENA, Calif.–(BUSINESS WIRE)–$RKLY #HMRC–Rockley Photonics Holdings Limited (NYSE: RKLY) (\u201cRockley\u201d), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced that it received 12.9 million pounds sterling ($15.5 million) for its fiscal 2020 R&D tax credit from HMRC, the tax ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/rockley-photonics-receives-2020-uk-rd-tax-credit-and-files-2021-rd-tax-credit-application\/","og_site_name":"Pharma Trend","article_published_time":"2022-12-29T15:02:10+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221229005044\/en\/1333692\/21\/Rockley-logo-500-x-500.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/rockley-photonics-receives-2020-uk-rd-tax-credit-and-files-2021-rd-tax-credit-application\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/rockley-photonics-receives-2020-uk-rd-tax-credit-and-files-2021-rd-tax-credit-application\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Rockley Photonics Receives 2020 UK R&D Tax Credit and Files 2021 R&D Tax Credit Application","datePublished":"2022-12-29T15:02:10+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/rockley-photonics-receives-2020-uk-rd-tax-credit-and-files-2021-rd-tax-credit-application\/"},"wordCount":571,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/rockley-photonics-receives-2020-uk-rd-tax-credit-and-files-2021-rd-tax-credit-application\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221229005044\/en\/1333692\/21\/Rockley-logo-500-x-500.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/rockley-photonics-receives-2020-uk-rd-tax-credit-and-files-2021-rd-tax-credit-application\/","url":"https:\/\/pharma-trend.com\/en\/rockley-photonics-receives-2020-uk-rd-tax-credit-and-files-2021-rd-tax-credit-application\/","name":"Rockley Photonics Receives 2020 UK R&D Tax Credit and Files 2021 R&D Tax Credit Application - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/rockley-photonics-receives-2020-uk-rd-tax-credit-and-files-2021-rd-tax-credit-application\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/rockley-photonics-receives-2020-uk-rd-tax-credit-and-files-2021-rd-tax-credit-application\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221229005044\/en\/1333692\/21\/Rockley-logo-500-x-500.jpg","datePublished":"2022-12-29T15:02:10+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/rockley-photonics-receives-2020-uk-rd-tax-credit-and-files-2021-rd-tax-credit-application\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/rockley-photonics-receives-2020-uk-rd-tax-credit-and-files-2021-rd-tax-credit-application\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/rockley-photonics-receives-2020-uk-rd-tax-credit-and-files-2021-rd-tax-credit-application\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221229005044\/en\/1333692\/21\/Rockley-logo-500-x-500.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221229005044\/en\/1333692\/21\/Rockley-logo-500-x-500.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/rockley-photonics-receives-2020-uk-rd-tax-credit-and-files-2021-rd-tax-credit-application\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Rockley Photonics Receives 2020 UK R&D Tax Credit and Files 2021 R&D Tax Credit Application"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52419","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52419"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52419\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52419"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52419"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52419"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}